Study for clinical application of hydroxyapatite orbital implant vascularization in detection by means of contrast-enhanced ultrasound

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-DDT-12002660

Enrollment

Unknown

Registered

2012-11-01

Start date

2011-06-07

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

vascularized detection after Hydroxyapatite orbital implantation

Interventions

Gold Standard:

Index test:

Eligibility

Sex/Gender

All

Age

15 Years to 65 Years

Inclusion criteria

Inclusion criteria: As a result of trauma or eye' desease requiring enucleation of eyeball and hydroxyapatite orbital implant patients cases

Exclusion criteria

Exclusion criteria: For tumor patients, less than 15 years of age and older than 65, serious cardiovascular patients not selected

Design outcomes

Primary

Measure	Time frame
area under curve, AUC;derived peak intensity, DPI;time to peak, TTP;vascularized area;	—

Secondary

Measure	Time frame
length of new vascular;Time-strenthen curve;average degree;	—

Countries

China

Contacts

Public ContactQihua Xu

xu7ganggang@163.com+86 13337911622

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 16, 2026